US › Healthcare

Gelteq Limited Ordinary Shares (GELS)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.53-1.19%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$89,296

Net profit

$-1.9M

Profit YoY

-157.2%

EPS

$-0.34

EPS estimate

$0.00

Net margin

-2,095.3%

Key statistics

Market cap

$5.6M

Forward P/E

0.0

P/B

0.56

Book value

$0.89

EPS (TTM)

$-0.51

52-week high

$2.02

52-week low

$0.39

50-day MA

$0.64

200-day MA

$0.81

Shareholding

Insiders

47.53%

Institutions

0.43%

Largest institutional holders

Fund	Stake
Wedbush Morgan Securities Inc	0.19%
Citadel Advisors Llc	0.13%
Two Sigma Investments LLC	0.09%
UBS Group AG	0.02%
Private Advisor Group, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Gelteq Limited Ordinary Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.